Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma. (1st December 2020) - Andersen, Michael Asger; Valentin, Rebecca; Dissing Sjö, Lene; Borgwardt, Line; Schmiegelow, Kjeld; Andersen, Mette Klarskov; Marvig, Rasmus L.; Yde, Christina Westmose; Niemann, Carsten Utoft